Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.63 |
| ▸ | OPRM1 | P35372 | 16/20 | 0.59 |
| ▸ | OPRL1 | P41146 | 16/20 | 0.59 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL302131 | 0.99 | EPHX2 (0.62) | EPHX2OPRM1OPRL1USP30NPC1 | |
| SCHEMBL2379652 | 0.93 | OPRM1 (0.69) | EPHX2OPRM1OPRL1 | |
| Hydrochloric Acid SCHEMBL302167 | 0.92 | OPRM1 (0.70) | EPHX2OPRM1OPRL1 | |
| SCHEMBL2380132 | 0.92 | OPRM1 (0.65) | EPHX2OPRM1OPRL1 | |
| Hydrochloric Acid SCHEMBL301795 | 0.91 | OPRM1 (0.66) | EPHX2OPRM1OPRL1 | |
| SCHEMBL302123 | 0.86 | OPRM1 (0.60) | EPHX2OPRM1OPRL1NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL2379631 | 0.85 | OPRM1 (0.61) | EPHX2OPRM1OPRL1NPC1RAB9A | |
| SCHEMBL2379972 | 0.83 | OPRM1 (0.57) | EPHX2OPRM1OPRL1 | |
| Hydrochloric Acid SCHEMBL302048 | 0.83 | OPRM1 (0.58) | EPHX2OPRM1OPRL1 | |
| SCHEMBL2379029 | 0.81 | OPRL1 (0.67) | OPRM1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8017630-B2 | Cyclohexylacetic acid compounds | GRUENENTHAL GMBH (DE) | 2011-09-13 | — | — | US | claimed |
| EP-1751093-B1 | SUBSTITUTED CYCLOHEXYLACETIC ACID DERIVATIVES | GRUENENTHAL GMBH (DE) | 2010-10-06 | — | — | EP | claimed |
| US-20070129347-A1 | Cyclohexylacetic acid compounds | GRUENENTHAL GMBH (DE) | 2007-06-07 | — | — | US | claimed |
| US-8017630-B2 | Cyclohexylacetic acid compounds | GRUENENTHAL GMBH (DE) | 2011-09-13 | — | — | US | disclosed |
| EP-1751093-B1 | SUBSTITUTED CYCLOHEXYLACETIC ACID DERIVATIVES | GRUENENTHAL GMBH (DE) | 2010-10-06 | — | — | EP | disclosed |
| US-20070129347-A1 | Cyclohexylacetic acid compounds | GRUENENTHAL GMBH (DE) | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129347-A1 | Cyclohexylacetic acid compounds | ACACA, HCAR2, PCCA | EPHX2 987/4885OPRM1 3702/4885OPRL1 2478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.